Analysis of Clinical End Points of Randomised Trials Including Bevacizumab and Chemotherapy versus Chemotherapy as First-line Treatment of Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Analysis of Clinical End Points of Randomised Trials Including Bevacizumab and Chemotherapy versus Chemotherapy as First-line Treatment of Metastatic Colorectal Cancer

Published:2016-10 Issue:10 Volume:28 Page:e155-e164
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Colloca G.,Venturino A.,Guarneri D.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference44 articles.

1. European cancer mortality predictions for the year 2014;Malvezzi;Ann Oncol,2014

2. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment;Grothey;J Clin Oncol,2004

3. Reporting results of cancer treatment;Miller;Cancer,1981

4. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J Natl Cancer Inst,2000

5. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surrogate Endpoints in Oncology: Overview of Systematic Reviews and Their Use for Health Decision Making in Mexico;Value in Health Regional Issues;2021-12

2. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework;Health Technology Assessment;2021-12

3. Reduction of derived neutrophil-to-lymphocyte ratio after four weeks predicts the outcome of patients receiving second-line chemotherapy for metastatic colorectal cancer;Cancer Immunology, Immunotherapy;2020-10-29

4. A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer;British Journal of Cancer;2020-09-11

5. Analysis of response-related endpoints in trials of first-line medical treatment of metastatic colorectal cancer;International Journal of Clinical Oncology;2019-07-09